Atlas Trials

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Clinical trial NCT02244281 · COMPLETED

Trial details

NCT number
NCT02244281
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lower Urinary Tract Symptoms
Start date
2001-05-01
Primary completion
2003-11-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.